Regeneron Pharmaceuticals, Inc...

NASDAQ: REGN
$621.40
+$7.02 (+1.1%)
Closing price January 21, 2022
Thursday's top analyst upgrades and downgrades included Beyond Meat, Delta Air Lines, Emerson Electric, Kimco Realty, Peloton Interactive, Pinterest, Plug Power, Range Resources, Roku,...
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Monday's top analyst upgrades and downgrades included Biogen, Cemex, Constellation Brands, Exxon Mobil, Fastly, Hilton Worldwide, McDonald's, Nike, PayPal and Peloton Interactive.
Friday afternoon's analyst upgrades and downgrades included Alibaba, AIG, Amgen, Applied Materials, Bath & Body Works, Delta Air Lines, Kohl’s, Macy’s, Snowflake, Tapestry and Walmart.
Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Monday's top analyst upgrades and downgrades included American Eagle Outfitters, Baidu, GameStop, Halliburton, Mosaic, Regeneron Pharmaceuticals, Salesforce.com, Take-Two Interactive Software and...
Wednesday's top analyst upgrades and downgrades included AbbVie, Albertsons, DuPont, Exxon Mobil, Home Depot, KB Home, Mastercard, Palantir and Twitter.
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Regeneron Pharma reported its third-quarter financial results before the markets opened on Thursday.
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including General Motors, T-Mobile and Uber.